Using an Online Patient Monitoring System to Improve Care for Children With Chronic Conditions
TriVoxHealth
Integrated Clinical Information Sharing System: Implementation and Mixed-Methods Evaluation of a Web-based Monitoring and Management System for Patients With Chronic Conditions
1 other identifier
interventional
946
1 country
1
Brief Summary
TriVox Health is an online system designed to make it easy for healthcare providers to monitor patients' disease symptoms and functioning over time and in between in-person visits (http://www.youtube.com/watch?v=VR1vcbx0Ef4). Using combined quality improvement and randomized clinical trial methods, we will evaluate the impact of TriVox on the health outcomes, patient/family experience of care, and healthcare utilization for children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD), asthma, autism, depression, and epilepsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2014
CompletedFirst Posted
Study publicly available on registry
March 27, 2014
CompletedStudy Start
First participant enrolled
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedJuly 14, 2020
July 1, 2020
5 years
March 21, 2014
July 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in caregiver-rated disease-specific symptoms
Caregiver-reported ratings on disease-specific symptom rating scale. For example, Vanderbilt ADHD Parent Rating Scale for ADHD; Asthma Control Test for asthma
Baseline to 12 months
Secondary Outcomes (3)
Number of patients with "red flag" alerts
1 month
Change in caregiver-rated global functioning
Baseline to 12 months
Experience of care
Baseline and after every ambulatory visit for up to 84 months
Other Outcomes (2)
Healthcare utilization
12 months
Direct out of pocket expenditures
12 months
Study Arms (2)
TriVox Active
EXPERIMENTALProvider using TriVox for clinical care
TriVox Delayed-start
NO INTERVENTIONProviders not using TriVox for clinical care
Interventions
Eligibility Criteria
You may qualify if:
- Pediatric patients with clinical diagnosis of ADHD, asthma, autism, depression, and/or epilepsy
- Patient receives care for these diagnoses from providers in participating ambulatory clinics (Primary Care, Adolescent Medicine, Developmental Medicine, Neurology, Psychiatry)
- Patient's primary caregiver enrolled in TriVox
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eugenia Chan, MD, MPH
Boston Children's Hospital
- PRINCIPAL INVESTIGATOR
Eric Fleegler, MD, MPH
Boston Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
March 21, 2014
First Posted
March 27, 2014
Study Start
December 1, 2014
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
July 14, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share